Medicare Enrolled

Dr. Dina Green, MD

Endocrinology · Wynnewood, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
100 E LANCASTER AVE, Wynnewood, PA 19096
6106491922
In practice since 2006 (20 years)
NPI: 1669404869 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Green from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Green? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Green

Dr. Dina Green is an endocrinology specialist in Wynnewood, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Green performed 4,887 Medicare services across 695 unique beneficiaries.

Between the years covered by Open Payments, Dr. Green received a total of $18,772 from 56 pharmaceutical and/or device companies across 1082 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Green is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 6% volume in PA $18,772 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,887
Medicare services
Top 6% in PA for endocrinology
695
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~244 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 3,900 $18 $55
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
355 $93 $235
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
233 $64 $151
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
107 $100 $225
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
94 $133 $331
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
92 $105 $302
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
83 $12 $62
New patient office visit, complex (60-74 min) 23 $156 $453
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$18,772
Total received (2018-2024)
Avg $2,682/year across 7 years
Top 16% in PA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
1,082
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,772 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,668
2023
$2,805
2022
$2,521
2021
$2,615
2020
$2,725
2019
$3,580
2018
$2,858

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$516
Novo Nordisk Inc
$371
Abbott Laboratories
$216
Amgen Inc.
$186
ABBVIE INC.
$61
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$59
Xeris Pharmaceuticals, Inc.
$52
Dexcom, Inc.
$42
Bayer Healthcare Pharmaceuticals Inc.
$35
Ascensia Diabetes Care Us Inc.
$28
SANOFI-AVENTIS U.S. LLC
$24
Mannkind Corporation
$24
IBSA Pharma Inc.
$19
CeQur Corporation
$18
Insulet Corporation
$17
Top 3 companies account for 66.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,785
Lilly USA, LLC
$2,678
Amgen Inc.
$1,750
SANOFI-AVENTIS U.S. LLC
$1,392
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,005
Merck Sharp & Dohme Corporation
$848
Dexcom, Inc.
$770
AstraZeneca Pharmaceuticals LP
$731
Xeris Pharmaceuticals, Inc.
$598
Abbott Laboratories
$589
Amarin Pharma Inc.
$508
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$508
Janssen Pharmaceuticals, Inc
$365
Merck Sharp & Dohme LLC
$329
Amneal Pharmaceuticals LLC
$326
Medtronic MiniMed, Inc.
$285
AbbVie, Inc.
$264
Corcept Therapeutics
$251
ABBVIE INC.
$216
AbbVie Inc.
$206
Radius Health, Inc.
$201
DEXCOM, INC.
$194
Insulet Corporation
$192
Mannkind Corporation
$182
Medtronic, Inc.
$180
Alexion Pharmaceuticals, Inc.
$153
IBSA Pharma Inc.
$143
Becton, Dickinson and Company
$112
Tandem Diabetes Care, Inc.
$89
Companion Medical, Inc.
$85
Bayer Healthcare Pharmaceuticals Inc.
$83
Regeneron Healthcare Solutions, Inc.
$80
Shire North American Group Inc
$77
Kowa Pharmaceuticals America, Inc.
$66
EISAI INC.
$53
CeQur Corporation
$48
Ipsen Biopharmaceuticals, Inc
$39
Ultragenyx Pharmaceutical Inc.
$30
Gemini Laboratories, LLC
$29
AngioDynamics, Inc.
$29
LifeScan, Inc.
$29
Ascensia Diabetes Care Us Inc.
$28
PFIZER INC.
$28
Zealand Pharma US, Inc.
$26
Currax Pharmaceuticals LLC
$24
Horizon Therapeutics plc
$19
Nevro Corp.
$19
Bigfoot Biomedical Inc
$17
Embecta Corp.
$17
Averitas Pharma Inc.
$17
Kyowa Kirin, Inc.
$16
Sunovion Pharmaceuticals Inc.
$16
Tolmar, Inc.
$15
Ferring Pharmaceuticals Inc.
$12
Eisai Inc.
$11
UCB, Inc.
$11
Top 3 companies account for 38.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · APRISO · AURYON LASER SYSTEM 100-120 VAC · Androgel · BAQSIMI · BASAGLAR · BD Nano · BD Nano 2nd Gen Pen Needle · BELSOMRA · BYDUREON · Belviq · CONTRAVE · CYCLOSET · CeQur Simplicity · Creon · Crysvita · Cryvista · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · Livalo · MAVYRET · MINIMED 770G · MOUNJARO · Macrilen · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · OT Verio Reflect "One Touch Meter and Strips" · Omnipod · OneTouch Verio Reflect · Ozempic · PRALUENT · Prandin · Prolia · QUTENZA · RECORLEV · RELISTOR · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · Senza · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tymlos · UBRELVY · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · Utibron · V-GO · Vascepa · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · ZEPBOUND · ZOMACTON · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Wynnewood?
Compare endocrinologists in the Wynnewood area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
202
Per 100K population
23.5
County median income
$111,521
Nearest hospital
MAIN LINE HOSPITAL LANKENAU
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Green is a mixed practice specialist, with above-average Medicare volume (top 6% in PA), with low-engagement industry engagement in the top 16% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Green experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Green performed 3,900 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Green receive payments from pharmaceutical companies?
Yes. Dr. Green received a total of $18,772 from 56 companies across 1,082 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Green's costs compare to other endocrinologists in Wynnewood?
Dr. Green's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Green) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →